|
|
Volumn 92, Issue 24, 2000, Pages 1970-1971
|
|
Effect of mifepristone approval on research remains to be seen
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL SURFACE RECEPTOR;
ESTROGEN RECEPTOR;
MIFEPRISTONE;
PROGESTERONE;
TAMOXIFEN;
ANTINEOPLASTIC ACTIVITY;
BRAIN TUMOR;
BREAST CANCER;
CANCER REGRESSION;
CANCER RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG MARKETING;
DRUG POTENTIATION;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FINANCE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MENINGIOMA;
NOTE;
OVARY CANCER;
PREGNANCY;
PRIORITY JOURNAL;
RASH;
|
|
EID: 0034694676
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/92.24.1970 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|